ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 826 - 840 of 5996 products
GenoImmune, a GBI Company, Completes Funding for NeoAntigen Cell Therapies
$5.00
Available
EQRx Starts US Phase III Trial of Hansoh’s EGFR for NSCLC
$5.00
Available
Frontier Reports Positive Results from Early Trial of COVID-19 Therapy
$5.00
Available
Insilico Closes $35 Million D2 Round; Will Expand AI Beyond Drug Discovery
$5.00
Available
Axcynsis Opens Shanghai R&D Center; Raises $15 Million
$5.00
Available
LianBio Completes Enrollment of Phase III Trial for Cardiomyopathy Therapy
$5.00
Available
Arbele Starts Australian Trial of CDH17xCD3 Bispecific for GI Cancers
$5.00
Available
Hansoh Enters $170 Million Agreement for Endometriosis/Uterine Fibroid Therapy
$5.00
Available
Inmagene and HutchMed Start Global Trial of BTK Inhibitor
$5.00
Available
Epigenic Therapeutics Raises $20 Million in Angel and Pre-A Rounds for Epigenetic Drugs
$5.00
Available
ImmVira Granted US Orphan Drug Status for Oncolytic Virus Candidate in Glioma
$5.00
Available
Innovent to Partner two Sanofi Cancer Assets in China; Sanofi Invests $305 Million in Innovent
$5.00
Available
Genuine Biotech Files for Hong Kong IPO to Support Novel Drugs Portfolio
$5.00
Available
Radiopharm Forms Collaboration to Develop PD-L1 Diagnostic/Therapeutic Antibody
$5.00
Available
ProfoundBio Cleared to Start US Trials of ADC for Solid Tumor Cancers
$5.00
Available